Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 3/20 | 0.32 |
| ▸ | ACACA | Q13085 | 3/20 | 0.32 |
| ▸ | DPP4 | P27487 | 3/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2886584 | 0.94 | ACACB (0.33) | ACACBACACADPP4CHRM2CHRM4 | |
| SCHEMBL2996875 | 0.92 | CNR2 (0.31) | ACACBACACA | |
| SCHEMBL5435809 | 0.92 | BACE1 (0.32) | ACACBACACABACE1 | |
| SCHEMBL5432156 | 0.89 | BACE1 (0.36) | BACE1 | |
| SCHEMBL5429034 | 0.89 | DPP4 (0.37) | ACACBACACADPP4SLC6A4SLC6A3 | |
| SCHEMBL3077698 | 0.86 | THRB (0.37) | — | |
| SCHEMBL3001186 | 0.79 | KMT2A (0.36) | — | |
| SCHEMBL2889210 | 0.78 | KMT2A (0.41) | — | |
| SCHEMBL11028523 | 0.77 | ACACB (0.39) | ACACBACACADPP4CHRM2CHRM4 | |
| SCHEMBL2070159 | 0.77 | ACACB (0.39) | ACACBACACADPP4CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383853-B2 | Method for preparing 2,6-diethyl-4-methylphenylacetic acid | BAYER CROPSCIENCE AG (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20100261934-A1 | Method for Preparing 2,6-Diethyl-4-Methylphenylacetic Acid | BAYER CROPSCIENCE AG (DE) | 2010-10-14 | — | — | US | disclosed |
| EP-2218710-A1 | Procedure for the preparation of 2,6-diethyl-4-methylphenylacetic acid | Bayer CropScience AG (DE) | 2010-08-18 | — | — | EP | disclosed |
| US-20080318776-A1 | 2,6-Diethyl-4-Methylphenyl-Substituted Tetramic Acid Derivatives | BAYER CROPSCIENCE AG (DE) | 2008-12-25 | — | — | US | disclosed |
| EP-1809635-A1 | 2,6-DIETHYL-4-METHYL-PHENYL-SUBSTITUTED TETRAMIC ACID DERIVATIVES | Bayer CropScience AG (DE) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006056282-A1 | 2,6-DIETHYL-4-METHYL-PHENYL-SUBSTITUTED TETRAMIC ACID DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2006-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261934-A1 | Method for Preparing 2,6-Diethyl-4-Methylphenylacetic Acid | DDT, TET1, DDC | ACACB 728/4885ACACA 1106/4885DPP4 289/4885 |
| US-20080318776-A1 | 2,6-Diethyl-4-Methylphenyl-Substituted Tetramic Acid Derivatives | DDT, TET1, TET3 | ACACB 1389/4885ACACA 2133/4885DPP4 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.